Previous reports of EGFR activating mutations (common mutations) described the frequency of exon 19 deletion mutations as 44.8% (2573/5741) and 39.8% for L858R mutations (2283/5731) in lung cancer [18, 22, 23]. This evidence concerns the gene EGFR and lung carcinoma.